NYSE:PBHPharmaceuticals
Prestige Consumer Healthcare (PBH) Margin Compression Reinforces Cautious Earnings Narratives
Prestige Consumer Healthcare (PBH) has reported Q3 2026 results with revenue of US$283.4 million and basic EPS of US$0.98, giving investors a fresh look at how its consumer health portfolio is translating into earnings power. The company has seen quarterly revenue move from US$283.8 million in Q2 2025 to US$283.4 million in Q3 2026, while basic EPS has ranged between US$0.86 and US$1.23 over that period. This sets the backdrop for trailing 12 month net profit margins that have compressed...